Gloria E Anyalechi1, Jaeyoung Hong1, Damien C Danavall1, Diana L Martin2, Sarah E Gwyn2, Patrick J Horner3, Brian H Raphael1, Robert D Kirkcaldy1, Ellen N Kersh1, Kyle T Bernstein1. 1. Division of Sexually Transmitted Diseases (STD) Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA. 2. Division of Parasitic Diseases and Malaria, Centers for Disease Control and Prevention, Atlanta, Georgia, USA. 3. Population Health Sciences and National Institute for Health Research, Health Protection Research Unit in Behavioural Science and Evaluation in Partnership with Public Health England, University of Bristol, Bristol, United Kingdom.
Abstract
BACKGROUND: Chlamydia trachomatis causes pelvic inflammatory disease (PID) and tubal infertility. Plasmid gene protein 3 antibody (Pgp3Ab) detects prior chlamydial infections. We evaluated for an association of high chlamydial seropositivity with sequelae using a Pgp3Ab multiplex bead array (Pgp3AbMBA). METHODS: We performed chlamydia Pgp3AbMBA on sera from women 18-39 years old participating in the 2013-2016 National Health and Nutrition Examination Survey (NHANES) with urine chlamydia nucleic acid amplification test results. High chlamydial seropositivity was defined as a median fluorescence intensity (MFI ≥ 50 000; low-positive was MFI > 551-<50 000. Weighted US population high-positive, low-positive, and negative Pgp3Ab chlamydia seroprevalence and 95% confidence intervals (CI) were compared for women with chlamydial infection, self-reported PID, and infertility. RESULTS: Of 2339 women aged 18-39 years, 1725 (73.7%) had sera, and 1425 were sexually experienced. Overall, 104 women had high positive Pgp3Ab (5.4% [95% CI 4.0-7.0] of US women); 407 had lowpositive Pgp3Ab (25.1% [95% CI 21.5-29.0]), and 914 had negative Pgp3Ab (69.5% [95% CI 65.5-73.4]). Among women with high Pgp3Ab, infertility prevalence was 2.0 (95% CI 1.1-3.7) times higher than among Pgp3Ab-negative women (19.6% [95% CI 10.5-31.7] versus 9.9% [95% CI 7.7-12.4]). For women with low Pgp3Ab, PID prevalence was 7.9% (95% CI 4.6-12.6) compared to 2.3% (95% CI 1.4-3.6) in negative Pgp3Ab. CONCLUSIONS: High chlamydial Pgp3Ab seropositivity was associated with infertility although small sample size limited evaluation of an association of high seropositivity with PID. In infertile women, Pgp3Ab may be a marker of prior chlamydial infection. Published by Oxford University Press for the Infectious Diseases Society of America 2021.
BACKGROUND: Chlamydia trachomatis causes pelvic inflammatory disease (PID) and tubal infertility. Plasmid gene protein 3 antibody (Pgp3Ab) detects prior chlamydial infections. We evaluated for an association of high chlamydial seropositivity with sequelae using a Pgp3Ab multiplex bead array (Pgp3AbMBA). METHODS: We performed chlamydia Pgp3AbMBA on sera from women 18-39 years old participating in the 2013-2016 National Health and Nutrition Examination Survey (NHANES) with urine chlamydia nucleic acid amplification test results. High chlamydial seropositivity was defined as a median fluorescence intensity (MFI ≥ 50 000; low-positive was MFI > 551-<50 000. Weighted US population high-positive, low-positive, and negative Pgp3Ab chlamydia seroprevalence and 95% confidence intervals (CI) were compared for women with chlamydial infection, self-reported PID, and infertility. RESULTS: Of 2339 women aged 18-39 years, 1725 (73.7%) had sera, and 1425 were sexually experienced. Overall, 104 women had high positive Pgp3Ab (5.4% [95% CI 4.0-7.0] of US women); 407 had lowpositive Pgp3Ab (25.1% [95% CI 21.5-29.0]), and 914 had negative Pgp3Ab (69.5% [95% CI 65.5-73.4]). Among women with high Pgp3Ab, infertility prevalence was 2.0 (95% CI 1.1-3.7) times higher than among Pgp3Ab-negative women (19.6% [95% CI 10.5-31.7] versus 9.9% [95% CI 7.7-12.4]). For women with low Pgp3Ab, PID prevalence was 7.9% (95% CI 4.6-12.6) compared to 2.3% (95% CI 1.4-3.6) in negative Pgp3Ab. CONCLUSIONS: High chlamydial Pgp3Ab seropositivity was associated with infertility although small sample size limited evaluation of an association of high seropositivity with PID. In infertile women, Pgp3Ab may be a marker of prior chlamydial infection. Published by Oxford University Press for the Infectious Diseases Society of America 2021.
Authors: S Menon; P Timms; J A Allan; K Alexander; L Rombauts; P Horner; M Keltz; J Hocking; W M Huston Journal: Clin Microbiol Rev Date: 2015-10 Impact factor: 26.132
Authors: Patrick J Horner; Gillian S Wills; Rosy Reynolds; Anne M Johnson; David A Muir; Alan Winston; Andrew J Broadbent; David Parker; Myra O McClure Journal: Sex Transm Infect Date: 2013-02-21 Impact factor: 3.519
Authors: Ann C Frisse; Jeanne M Marrazzo; Nhial T Tutlam; Courtney A Schreiber; Stephanie B Teal; David K Turok; Jeffrey F Peipert Journal: Am J Obstet Gynecol Date: 2016-12-14 Impact factor: 8.661
Authors: Anne Z Steiner; Michael P Diamond; Richard S Legro; William D Schlaff; Kurt T Barnhart; Peter R Casson; Gregory M Christman; Ruben Alvero; Karl R Hansen; William M Geisler; Tracey Thomas; Nanette Santoro; Heping Zhang; Esther Eisenberg Journal: Fertil Steril Date: 2015-09-25 Impact factor: 7.329
Authors: Ali N Russell; Xiaojing Zheng; Catherine M O'Connell; Brandie D Taylor; Harold C Wiesenfeld; Sharon L Hillier; Wujuan Zhong; Toni Darville Journal: J Infect Dis Date: 2015-09-07 Impact factor: 5.226
Authors: S Menon; S H Stansfield; M Walsh; E Hope; L Isaia; A A Righarts; T Niupulusu; S V A Temese; L Iosefa-Siitia; L Auvaa; S A Tapelu; M F Motu; T Suaalii-Sauni; P Timms; P C Hill; W M Huston Journal: BMC Infect Dis Date: 2016-04-21 Impact factor: 3.090
Authors: Sarah Gwyn; Gretchen Cooley; Brook Goodhew; Stephan Kohlhoff; Natalie Banniettis; Ryan Wiegand; Diana L Martin Journal: Am J Trop Med Hyg Date: 2017-09-21 Impact factor: 2.345